Share Email Print

Proceedings Paper

Comparison of ALA and Photofrin in two rat glioma models
Author(s): Sarah A. Ziegler; Casey Hall; Cherisse Loucks; Steen J. Madsen; Stephen W. Carper
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Photodynamic therapy (PDT) shows good promise as an adjuvant therapy for the treatment of gliomas. PDT requires the use of a photosensitizer but there have been few studies in which they have been directly compared. Two rat brain glioma cell lines, BT4C and F98 were used to study the effects of Photofrin (PF) and aminolevulinic acid (ALA) as photosensitizers. Both compounds were able to sensitize cells to red light (635nm) however, PF treated (2.5 &mgr;g/ml) cells displayed more cell death than ALA treated (1 mM) cells. ALA-PDT treated cells did not have a block in the cell cycle while PF-PDT treated cells had a fluence dependent G1 block 24 hrs after treatment. The BT4C cell line also displayed a G2 cell cycle block. Both photosensitizers were able to induce apoptosis as measured by flow cytometry but only PF-PDT was able to induce necrosis at the fluence rates investigated (1-20 J/cm2). These differences in cellular responses to ALA and

Paper Details

Date Published: 23 March 2007
PDF: 9 pages
Proc. SPIE 6424, Photonic Therapeutics and Diagnostics III, 64242E (23 March 2007); doi: 10.1117/12.716527
Show Author Affiliations
Sarah A. Ziegler, Univ. of Texas Medical Branch at Galveston (United States)
Casey Hall, Univ. of Nevada/Las Vegas (United States)
Cherisse Loucks, Univ. of Michigan (United States)
Steen J. Madsen, Univ. of Nevada/Las Vegas (United States)
Stephen W. Carper, Univ. of Nevada/Las Vegas (United States)

Published in SPIE Proceedings Vol. 6424:
Photonic Therapeutics and Diagnostics III
Henry Hirschberg M.D.; Brian Jet-Fei Wong M.D.; Reza S. Malek M.D.; Kenton W. Gregory M.D.; Nikiforos Kollias M.D.; Bernard Choi; Steen J. Madsen; Guillermo J. Tearney M.D.; Justus F. R. Ilgner M.D.; Haishan Zeng, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?